Skip to main content
SpringerLink
Log in

Post-inflammatory Hyperpigmentation

  • Chapter
  • First Online:
Pigmentary Skin Disorders

Part of the book series: Updates in Clinical Dermatology ((UCD))

Abstract

Post-inflammatory hyperpigmentation (PIH) is a common dermatosis most often seen in those with skin of color. PIH results when cutaneous inflammation or injury promotes activation of cytokines that induce melanin production and dispersion in the epidermis. Damage to the basement membrane results in pigment incontinence and eventual phagocytosis by melanophages in the upper dermis. The most common causes of PIH include acne, lichen planus, contact dermatitis, mechanical trauma, and skin-directed physical therapy such as dermabrasion, chemical peels, and laser surgery. PIH is a clinical diagnosis with light–dark brown macules or patches at the site of inflammation or trauma. Prevention is critical given the well-documented adverse effects on quality of life as well as the management challenge that it presents. PIH can take months to years to fade away. Diverse treatment modalities have been documented with variable success and include topical preparations, chemical peels, and laser therapy. Currently, the gold-standard treatment for PIH is 4% hydroquinone in combination with photoprotection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ruiz-Maldonado R, Dela Luz Orozco-Covarrubias M. Postinflammatory hypopigmentation and hyperpigmentation. Semin Cutan Med Surg. 1997;16(1):36–43.

    Article  CAS  PubMed  Google Scholar 

  2. Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20–31.

    PubMed  PubMed Central  Google Scholar 

  3. Callender VD, St.Surin-Lord S, Davis EC, Maclin M. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol. 2011;12(2):87–99.

    Article  PubMed  Google Scholar 

  4. Zawar V, Agarwal M, Vasudevan B. Treatment of postinflammatory pigmentation due to acne with Q-switched neodymium-doped yttrium aluminum garnet in 78 Indian cases. J Cutan Aesthet Surg. 2015;8(4):222–6.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Abad-Casintahan F, Chow S, Goh C, Kubba R, Hayashi N, Noppakun N, et al. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol. 2016;43(7):826–8.

    Article  PubMed  Google Scholar 

  6. Epstein JH. Postinflammatory hyper-pigmentation. Clin Dermatol. 1989;7(2):55–65.

    Article  CAS  PubMed  Google Scholar 

  7. Halder RM, Nootheti PK, Lanka S, Asia S. Ethnic skin disorders overview. J Am Acad Dermatol. 2003;48(6):143–8.

    Article  Google Scholar 

  8. Halder R, Grimes P, McLaurin C. Incidence of common dermatoses in a predominately black dermatologic practice. Cutis. 1983;32:388–90.

    CAS  PubMed  Google Scholar 

  9. Alexis A, Sergay A, Taylor S. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis. 2007;80:387–94.

    PubMed  Google Scholar 

  10. Tomita Y, Maeda K, Tagami H. Melanocyte-stimulating properties of arachidonic metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res. 1992;5:357–61.

    Article  CAS  PubMed  Google Scholar 

  11. Cardinali G, Kovacs D, Picardo M. Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo. Ann Dermatol Venereol. 2012;139(Suppl):S148–52. Available from: https://doi.org/10.1016/S0151-9638(12)70127-8.

    Article  PubMed  Google Scholar 

  12. Taylor S, Grimes P, Lim J, Im S, Lui H. Postinflammatory hyperpigmentation. J Cutan Med Surg [Internet]. 2009;13(4):183–91. Available from: http://cms.sagepub.com/lookup/doi/10.2310/7750.2009.08077

    Article  Google Scholar 

  13. Youn SW. In vivo model for postinflammatory hyperpigmentation: a step forward. Br J Dermatol [Internet]. 2016;174(4):721–2. Available from: http://doi.wiley.com/10.1111/bjd.14333

    Article  CAS  Google Scholar 

  14. Papa C, Kligman A. The behavior of melanocytes in inflammation. J Invest Dermatol. 1965;45:465–73.

    Article  CAS  PubMed  Google Scholar 

  15. Wintroub BU, Stern R. Cutaneous drug reactions: pathogenesis and clinical classification. J Am Acad Dermatol [Internet]. American Academy of Dermatology, Inc. 1985;13(2 Pt 1):167–79. Available from: https://doi.org/10.1016/S0190-9622(85)70156-9

    Article  CAS  Google Scholar 

  16. Callender V. Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004;17(2):184–95.

    Article  PubMed  Google Scholar 

  17. Mandy SH. Tretinoin in the preoperative and postoperative management of dermabrasion. J Am Acad Dermatol [Internet]. 1986;15(4):878–9. Available from: http://www.sciencedirect.com/science/article/pii/S0190962286702454

    Article  CAS  Google Scholar 

  18. Chan HHL. Effective and safe use of lasers, light sources, and radiofrequency devices in the clinical management of Asian patients with selected dermatoses. Lasers Surg Med. 2005;37(3):179–85.

    Article  PubMed  Google Scholar 

  19. Li Y-H, Chen JZS, Wei H-C, Wu Y, Liu M, Xu Y-Y, et al. Efficacy and safety of intense pulsed light in treatment of melasma in Chinese patients. Dermatol Surg [Internet]. 2008;34(5):693–700–1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18318729.

    CAS  PubMed  Google Scholar 

  20. Negishi K, Kushikata N, Tezuka Y, Takeuchi K, Miyamoto E, Wakamatsu S, et al. Study of the incidence and nature of “very subtle epidermal melasma” in relation to intense pulsed light treatment. Dermatologic Surg. 2004;30(6):881–6.

    Google Scholar 

  21. Chan H, Fung W, Ying S, Kono T. An in vivo trial comparing the use of different types of 532 nm Nd:YAG lasers in the treatment of facial lentigines in oriental patients. Dermatol Surg. 2000;26(8):743–9.

    Article  CAS  PubMed  Google Scholar 

  22. Murphy M, Huang M. Q-switched ruby laser treatment of benign pigmented lesions in Chinese skin. Ann Acad Med Singap. 1994;23(1):60–6.

    CAS  PubMed  Google Scholar 

  23. Sriprachya-anunt S, Marchell N, Fitzpatrick R, Goldman M, Rostan E. Facial resurfacing in patients with Fitzpatrick skin type IV. Lasers Surg Med. 2002;30:86–92.

    Article  PubMed  Google Scholar 

  24. Shamsaldeen O, Peterson J, Goldman M. The adverse events of deep fractional CO(2): a retrospective study of 490 treatments in 374 patients. Lasers Surg Med. 2011;43(6):453–6.

    Article  PubMed  Google Scholar 

  25. Lee S, Lee M, Noh T, Choi K, Won C, Chang S, et al. Successful treatment of tattoos with a picosecond 755-nm alexandrite laser in Asian skin. Ann Dermatol. 2016;28(5):673–5.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Haimovic A, Brauer J, Cindy Y, Geronemus R. Safety of a picosecond laser with diffractive lens array (DLA) in the treatment of Fitzpatrick skin types IV to VI: a retrospective review. J Am Acad Dermatol. 2016;74(5):931–6.

    Article  PubMed  Google Scholar 

  27. DC W, Fletcher L, Guiha I, Goldman MP. Evaluation of the safety and efficacy of the picosecond alexandrite laser with specialized lens array for treatment of the photoaging décolletage. Lasers Surg Med. 2016;48(2):188–92.

    Article  Google Scholar 

  28. Chan HHL, Manstein D, CS Y, Shek S, Kono T, Wei WI. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med. 2007;39(5):381–5.

    Article  PubMed  Google Scholar 

  29. Vashi NA, Kundu RV. Facial hyperpigmentation: causes and treatment. Br J Dermatol. 2013;169:41–56.

    Article  PubMed  Google Scholar 

  30. Tienthavorn T, Tresukosol P, Sudtikoonaseth P. Patch testing and histopathology in Thai patients with hyperpigmentation due to erythema dyschromicum perstans, Lichen planus pigmentosus, and pigmented contact dermatitis. Asian Pacific J Allergy Immunol. 2014;32(2):185–92.

    Google Scholar 

  31. Lacz NL, Vafaie J, Kihiczak NI, Schwartz RA. Postinflammatory hyperpigmentation: a common but troubling condition. Int J Dermatol. 2004;43(5):362–5.

    Article  PubMed  Google Scholar 

  32. Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatology Clin. 2000;18(1):91–8.

    Article  CAS  Google Scholar 

  33. Calonje J, Brenn T, Lazar A, McKee P. McKee’s pathology of the skin: with clinical correlations. 4th ed. China: Elsevier/Saunders; 2012. p. 932–3.

    Google Scholar 

  34. Goldsmith L, Katz S, Gilchrest B, Paller A, Leffell D, Wolff K. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012. p. 804–25.

    Google Scholar 

  35. Wanitphakdeedecha R, Phuardchantuk R, Manuskiatti W. The use of sunscreen starting on the first day after ablative fractional skin resurfacing. J Eur Acad Dermatology Venereol. 2013:1522–8.

    Article  PubMed  Google Scholar 

  36. Goldman M. The use of hydroquinone with facial laser resurfacing. J Cutan Laser Ther. 2000;2(2):73–7.

    Article  CAS  PubMed  Google Scholar 

  37. Nutjira Cheyasa K, Manuskiatti W, Maneeprasopcho KP, Wanitpha Kdee Decha R. Topical corticosteroids minimise the risk of postinflammatory hyperpigmentation after ablative fractional Co2laser resurfacing in Asians. Acta Derm Venereol. 2015;95(2):201–5.

    Article  Google Scholar 

  38. Cho S, Lee S, Kang J, Kim Y, Chung W, Oh S. The efficacy and safety of 10,600-nm carbon dioxide fractional laser for acne scars in Asian patients. Dermatol Surg. 2009;35(12):1955–61.

    Article  CAS  PubMed  Google Scholar 

  39. Song HS, Park JY, Kim SJ, Kang HY. In vivo time-sequential histological study focused on melanocytes: suggestion of golden time for intervention to prevent post-laser pigmentary changes. J Eur Acad Dermatology Venereol. 2016;30(2):306–10.

    Article  CAS  Google Scholar 

  40. Holme S, Beattie P, Fleming C. Cosmetic camouflage advice improves quality of life. Br J Dermatol. 2002;147(5):946–9.

    Article  CAS  PubMed  Google Scholar 

  41. McMichael L. Skin camouflage. Br J Dermatol. 2012;344:d7921.

    Google Scholar 

  42. Nonni J. Medical makeup: the correction of hyperpigmentation disorders. Ann Dermatol Venereol. 2012;139(Suppl 4):S170–6. Available from: https://doi.org/10.1016/S0151-9638(12)70131-X.

    Article  PubMed  Google Scholar 

  43. Grimes P. Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg. 2009;28(2):77–85.

    Article  CAS  PubMed  Google Scholar 

  44. Rossi A, Perez M. Treatment of hyperpigmentation. Facial Plast Surg Clin North Am. 2011;19(2):313–24.

    Article  PubMed  Google Scholar 

  45. Badreshia-Bansal S, Draelos Z. Insight into skin lightening cosmeceuticals for women of color. J Drugs Dermatol. 2007;6(1):32–9.

    PubMed  Google Scholar 

  46. Stratigos AJ, Katsambas AD. Optimal management of recalcitrant disorders of hyperpigmentation in dark-skinned patients. Am J Clin Dermatol. 2004;5(3):161–8.

    Article  PubMed  Google Scholar 

  47. Touart D, Sau P. Cutaneous deposition diseases. Part II. J Am Acad Dermatol. 1998;39(4 Pt 1):527–44.

    Article  CAS  PubMed  Google Scholar 

  48. Fleischer AJ, Schwartzel E, Colby S, Altman D. The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies. J Am Acad Dermatol. 2000;42(3):459–67.

    Article  PubMed  Google Scholar 

  49. Taylor S, Callender V. A multicenter, 12-week, phase 3b trial: a combination solution of mequinol 2%/tretinoin 0.01% 60. vs hydroquinone 4% cream in the treatment of mild to moderate postinflammatory hyperpigmentation. J Am Acad Dermatol. 2006;54(Suppl):AB194.

    Google Scholar 

  50. Kang H, Valerio L, Bahadoran P, Ortonne J. The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review. Am J Clin Dermatol. 2009;10(4):251–60.

    Article  PubMed  Google Scholar 

  51. Jacyk W, Mpofu P. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients. Cutis. 2001;68(4 Suppl):48–54.

    CAS  PubMed  Google Scholar 

  52. Nguyen Q, Bui T. Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. Int J Dermatol. 1995;34(2):75–84.

    Article  CAS  PubMed  Google Scholar 

  53. Shokeen D. Postinflammatory Hyperpigmentation in Patients With Skin of Color co co. 2016;97(January):9–11.

    Google Scholar 

  54. Maeda K, Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther. 1996;276:765–9.

    CAS  PubMed  Google Scholar 

  55. Zhu W, Gao J. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. J Investig Dermatol Symp Proc [Internet]. Elsevier Masson SAS; 2008;13(1):20–4. Available from: https://doi.org/10.1038/jidsymp.2008.8.

    Article  CAS  PubMed  Google Scholar 

  56. Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20–31.

    Article  CAS  PubMed  Google Scholar 

  57. Kimball AB, Kaczvinsky JR, Li J, Robinson LR, Matts PJ, Berge CA, et al. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial. Br J Dermatol. 2010;162(2):435–41.

    Article  CAS  PubMed  Google Scholar 

  58. Bissett D, Robinson L, Raleigh P, Miyamoto K, Hakozaki T, Li J, et al. Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine. J Cosmet Dermatol. 2007;6(1):20–6.

    Article  PubMed  Google Scholar 

  59. Espinal-Perez LE, Moncada B, Castanedo-Cazares JP. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol. 2004;43(8):604–7.

    Article  CAS  PubMed  Google Scholar 

  60. Draelos Z. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther. 2007;20:308–13.

    Article  PubMed  Google Scholar 

  61. Fu B, Li H, Wang X, Lee FSC, Cui S. Isolation and identification of flavonoids in licorice and a study of their inhibitory effects on tyrosinase. J Agric Food Chem. 2005;53(19):7408–14.

    Article  CAS  PubMed  Google Scholar 

  62. Yokota T, Nishio H, Kubota Y, Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res [Internet]. 1998;11(6):355–61. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-0032239708&partnerID=40&md5=b1e30198618d92632c40359d552c332b

    Article  CAS  Google Scholar 

  63. Paine C, Sharlow E, Liebel F, Eisinger M, Shapiro S, Seiberg M. An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway. J Invest Dermatol [Internet]. Elsevier Masson SAS; 2001;116(4):587–95. Available from: https://doi.org/10.1046/j.1523-1747.2001.01291.x.

    Article  CAS  PubMed  Google Scholar 

  64. Sah A, Stephens T, Kurtz E. Topical acne treatment improves postacne postinflammatory hyperpgmentation (PIH) in skin of color [poster]. J Am Acad Dermatol 2005;52(Suppl):P25.

    Google Scholar 

  65. Kligman A, Willis I. A new formula for depigmenting human skin. Arch Dermatol 1975;111(1):40–48.

    Article  CAS  PubMed  Google Scholar 

  66. Yoshimura K, Harii K, Aoyama T, Shibuya F, Iga T. A new bleaching protocol for hyperpigmented skin lesions with a high concentration of all-trans retinoic acid aqueous gel. Aesthet Plast Surg. 1999;23(4):285–91.

    Article  CAS  Google Scholar 

  67. Yoshimura K, Harii K, Aoyama T, Iga T. Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals. Plast Reconstr Surg. 2000;105(3):1097–108.

    Article  CAS  PubMed  Google Scholar 

  68. Cook-Bolden F. The efficacy and tolerability of a combination cream containing 4% hydroquinone in the treatment of post-inflammatory hyperpigmentation in skin types IV-VI. Cosmet Dermatol. 2004;17:149–55.

    Google Scholar 

  69. Eimpunth S, Wanitphadeedecha R, Manuskiatti W. A focused review on acne-induced and aesthetic procedure-related postinflammatory hyperpigmentation in Asians. J Eur Acad Dermatology Venereol. 2013;27(SUPPL. 1):7–18.

    Article  Google Scholar 

  70. Burns R, Prevost-Blank P, Lawry M, Lawry T, Faria D, Fivenson D. Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study. SODermatol Surg. 1997;23(3):171–4.

    Article  CAS  Google Scholar 

  71. Grimes P. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999;25(1):18.

    Article  CAS  PubMed  Google Scholar 

  72. Ahn H, Kim I. Whitening effect of salicylic acid peels in Asian patients. Dermatol Surg. 2006;32(3):372–5.

    CAS  PubMed  Google Scholar 

  73. Vijay Z, Madhuri A, Biju V. Treatment of postinflammatory pigmentation due to acne with Q-switched neodymium-doped yttrium aluminum garnet in 78 Indian cases. J Cutan Aesthet Surg. 2015;8(4):222–6.

    Article  Google Scholar 

  74. Kim S, Cho K. Treatment of facial postinflammatory hyperpigmentation with facial acne in Asian patients using a Q-switched neodymium-doped yttrium aluminum garnet laser. Dermatol Surg. 2010;36:1374–80.

    Article  CAS  PubMed  Google Scholar 

  75. Cho S, Park S, Kim J, Al E. Treatment of post-inflammatory hyper- pigmentation using 1064-nm Q-switched Nd:YAG laser with low fluence: report of three cases. J Eur Acad Dermatol Venereol. 2009;23:12061207.

    Google Scholar 

  76. Park J, Kim J, Kim W. Treatment of persistent facial postinflammatory hyperpigmentation with novel pulse-in-pulse mode intense pulsed light. Dermatol Surg. 2016;42(2):218–24.

    Article  PubMed  Google Scholar 

  77. Katz T, Goldberg L, Firoz B, Friedman P. Fractional photothermolysis for the treatment of postinflammatory hyperpigmentation. Dermatol Surg. 2009;35:1844–8.

    Article  CAS  PubMed  Google Scholar 

  78. Rokhsar C, Ciocon D. Fractional photothermolysis for the treatment of postinflammatory hyperpigmentation after carbon dioxide laser resurfacing. Dermatol Surg. 2009;35:535–7.

    Article  CAS  PubMed  Google Scholar 

  79. Kroon M, Wind B, Meesters A, Wolkerstorfer A, Wietze van der Veen J, Bos J, et al. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study. J Dermatolog Treat. 2012;23:339–44.

    Article  PubMed  Google Scholar 

  80. Oram Y, Akkaya AD. Refractory postinflammatory hyperpigmentation treated with fractional CO2 laser. J Clin Aesthet Dermatol. 2014;7(3):42–4.

    PubMed  PubMed Central  Google Scholar 

  81. Brauer J, Kazlouskaya V, Alabdulrazzaq H, Bae Y, Bernstein L, Anolik R, et al. Use of a picosecond pulse duration laser with specialized optic for treatment of facial acne scarring. JAMA Dermatol. 2015;151(3):278–84.

    Article  PubMed  Google Scholar 

  82. Forbat E, Al-Niaimi F. The use of picosecond lasers beyond tattoos. J Cosmet Laser Ther [Internet]. 2016;18(6):345–7. Available from: https://www.tandfonline.com/doi/full/10.1080/14764172.2016.1188209

    Article  CAS  Google Scholar 

  83. Padhi T, Pradhan S. Oral tranexamic acid with fluocinolone-based triple combination cream versus fluocinolone-based triple combination cream alone in melasma: an open labeled randomized comparative trial. Indian J Dermatol. 2015;60(5):520.

    PubMed  PubMed Central  Google Scholar 

  84. Lee H, Thng T, Goh C. Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol. 2016;75(2):385–92.

    Article  CAS  PubMed  Google Scholar 

  85. Lee YB, Park SM, Kim J-W, Yu DS. Combination treatment of low-fluence Q-switched Nd:YAG laser and oral tranexamic acid for post-inflammatory hyperpigmentation due to allergic contact dermatitis to henna hair dye. J Cosmet Laser Ther [Internet]. 2016;18(2):95–7. Available from: http://www.tandfonline.com/doi/full/10.3109/14764172.2015.1114634

    Article  Google Scholar 

  86. Katoulis A, Alevizou A, Bozi E, Makris M, Zafeiraki A, Mantas N, et al. A randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines. Clin Exp Dermatol. 2010;35(5):473–6.

    Article  CAS  PubMed  Google Scholar 

  87. Kasraee B, Handjani F, Parhizgar A, Omrani G, Fallahi M, Amini M, et al. Topical methimazole as a new treatment for postinflammatory hyperpigmentation: report of the first case. Dermatology. 2005;211(4):360–2.

    Article  CAS  PubMed  Google Scholar 

  88. Choi S, Lee S, Kim J, Chung M, Park Y. Aloesin inhibits hyperpigmentation induced by UV radiation. Clin Exp Dermatol. 2002;27(6):513–5.

    Article  CAS  PubMed  Google Scholar 

  89. Tirado-Sánchez A, Santamaría-Román A, Ponce-Olivera R. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma. Int J Dermatol. 2009;48(8):893–5.

    Article  PubMed  Google Scholar 

  90. Draelos Z. A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone. J Am Acad Dermatol. 2015;72:105.

    Article  CAS  PubMed  Google Scholar 

  91. Mansouri P, Farshi S, Hashemi Z, Kasraee B. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial. Br J Dermatol. 2015;173(1):209–17.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, St. Vincent’s Hospital, Fitzroy, VIC, Australia

    Michelle Rodrigues

  2. Dermatology Department, Hospital Universitario Dr. José Eleuterio González de la Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico

    Ana Sofia Ayala-Cortés

Authors
  1. Michelle Rodrigues
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Sofia Ayala-Cortés
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Dermatology, Fiona Stanley Hospital and University of Western Australia, Perth, Western Autralia, Australia

    Prasad Kumarasinghe

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rodrigues, M., Ayala-Cortés, A.S. (2018). Post-inflammatory Hyperpigmentation. In: Kumarasinghe, P. (eds) Pigmentary Skin Disorders. Updates in Clinical Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-70419-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-70419-7_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-70418-0

  • Online ISBN: 978-3-319-70419-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation